D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 65 Citations 16,053 168 World Ranking 1527 National Ranking 39

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Antibiotics
  • Bacteria

Patrick Francioli focuses on Internal medicine, Immunology, Surgery, Endocarditis and Cohort study. His work carried out in the field of Internal medicine brings together such families of science as Didanosine and Zidovudine. The Immunology study combines topics in areas such as Gastroenterology, Odds ratio, Acquired immunodeficiency syndrome and Viral load.

His research in Acquired immunodeficiency syndrome intersects with topics in Survival analysis, Incidence and Hazard ratio. Patrick Francioli interconnects Neutropenia, Microbiology, Streptococcus, Viridans streptococci and Ceftriaxone in the investigation of issues within Endocarditis. His study in Cohort study is interdisciplinary in nature, drawing from both Logistic regression and Cohort.

His most cited work include:

  • Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. (804 citations)
  • Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. (569 citations)
  • AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. (433 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Immunology, Microbiology, Surgery and Typing. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Pseudomonas aeruginosa and Transmission. The concepts of his Immunology study are interwoven with issues in Epidemiology, Dermatology, Acquired immunodeficiency syndrome, Viral load and Cohort.

His Acquired immunodeficiency syndrome research incorporates elements of Incidence, Cohort study and Hazard ratio. His research integrates issues of Endocarditis and Methicillin-resistant Staphylococcus aureus, Staphylococcus aureus in his study of Microbiology. His Typing research is multidisciplinary, incorporating perspectives in Ribotyping, Molecular epidemiology, Pneumocystis carinii and Pulsed-field gel electrophoresis.

He most often published in these fields:

  • Internal medicine (23.94%)
  • Immunology (21.28%)
  • Microbiology (20.21%)

What were the highlights of his more recent work (between 2005-2021)?

  • Microbiology (20.21%)
  • Immunology (21.28%)
  • Internal medicine (23.94%)

In recent papers he was focusing on the following fields of study:

Patrick Francioli mainly focuses on Microbiology, Immunology, Internal medicine, Intensive care medicine and Genetics. His research investigates the link between Microbiology and topics such as Staphylococcus aureus that cross with problems in Molecular epidemiology. His Immunology study incorporates themes from Odds ratio, Pregnancy, Cohort study and Cohort.

His work deals with themes such as Pulmonary tuberculosis and Antibiotics, Antibacterial agent, which intersect with Internal medicine. The study incorporates disciplines such as Transmission, Pseudomonas aeruginosa and Bacteremia in addition to Intensive care medicine. The concepts of his Incidence study are interwoven with issues in Viremia, Poisson regression, Acquired immunodeficiency syndrome and Viral load.

Between 2005 and 2021, his most popular works were:

  • Cohort profile: the Swiss HIV Cohort study (291 citations)
  • Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. (223 citations)
  • Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. (137 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Bacteria
  • Antibiotics

Patrick Francioli spends much of his time researching Microbiology, Methicillin-resistant Staphylococcus aureus, Staphylococcus aureus, Genotype and Immunology. His Microbiology study integrates concerns from other disciplines, such as Environmental swab, Outbreak and Acinetobacter baumannii. His work deals with themes such as Biopsy, Epidemiology and Typing, which intersect with Genotype.

He has researched Immunology in several fields, including Odds ratio, Logistic regression, Cohort study and Cohort. His Cohort research is within the category of Internal medicine. Patrick Francioli studies Incidence which is a part of Internal medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

Gilbert Greub;Bruno Ledergerber;M. Battegay;P. Grob.
The Lancet (2000)

1230 Citations

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study.

Matthias Egger;Bernard Hirschel;Patrick Francioli;Philippe Sudre.
BMJ (1997)

881 Citations

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

Bruno Ledergerber;M. Egger;V. Erard;R. Weber.
(1999)

655 Citations

Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis

A Babiker;S Darby;D De Angelis;D Kwart.
The Lancet (2000)

610 Citations

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

Philippe Eggimann;Patrick Francioli;Jacques Bille;Remy Schneider.
Critical Care Medicine (1999)

537 Citations

Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis

Philippe Moreillon;J. M. Entenza;Patrick Francioli;D. McDevitt.
Infection and Immunity (1995)

478 Citations

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

Jacques Fellay;Bruno Ledergerber;Enos Bernasconi;Hansjakob Furrer.
The Lancet (2001)

472 Citations

Cohort profile: the Swiss HIV Cohort study

Franziska Schoeni-Affolter;Bruno Ledergerber;Martin Rickenbach;Christoph Rudin.
International Journal of Epidemiology (2010)

471 Citations

Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial.

Guy Prod'hom;Philippe Leuenberger;Jacques Koerfer;Andre Blum.
Annals of Internal Medicine (1994)

460 Citations

Bacteremia due to viridans streptococci in neutropenic patients: A review

Pierre-Yves Bochud;Thierry Calandra;Patrick Francioli.
The American Journal of Medicine (1994)

385 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Patrick Francioli

Enos Bernasconi

Enos Bernasconi

Universita della Svizzera Italiana

Publications: 201

Manuel Battegay

Manuel Battegay

University Hospital of Basel

Publications: 182

Matthias Cavassini

Matthias Cavassini

University of Lausanne

Publications: 166

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 152

Hansjakob Furrer

Hansjakob Furrer

University of Bern

Publications: 145

Bruno Ledergerber

Bruno Ledergerber

University of Zurich

Publications: 123

Rainer Weber

Rainer Weber

University of Zurich

Publications: 100

Pietro Vernazza

Pietro Vernazza

University of St. Gallen

Publications: 97

Matthias Egger

Matthias Egger

University of Bern

Publications: 96

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 79

Sabine Yerly

Sabine Yerly

University of Geneva

Publications: 76

Jürg Böni

Jürg Böni

University of Zurich

Publications: 72

Thomas Klimkait

Thomas Klimkait

University of Basel

Publications: 69

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 67

Caroline Sabin

Caroline Sabin

University College London

Publications: 65

Heiner C. Bucher

Heiner C. Bucher

University Hospital of Basel

Publications: 62

Trending Scientists

Michael Rosenblum

Michael Rosenblum

University of Potsdam

Michael S. Wogalter

Michael S. Wogalter

North Carolina State University

Izzat M. Idriss

Izzat M. Idriss

University of California, Davis

Claude Lecomte

Claude Lecomte

University of Lorraine

Colin Eaborn

Colin Eaborn

University of Sussex

Dawen Zeng

Dawen Zeng

Huazhong University of Science and Technology

W. Ford Doolittle

W. Ford Doolittle

Dalhousie University

Shunji Natori

Shunji Natori

University of Tokyo

Evandro Leite de Souza

Evandro Leite de Souza

Federal University of Paraíba

Thomas Ferenci

Thomas Ferenci

University of Sydney

Yin Li

Yin Li

Chinese Academy of Sciences

Hans Link

Hans Link

Karolinska Institute

Sterling C. Johnson

Sterling C. Johnson

University of Wisconsin–Madison

Padmanee Sharma

Padmanee Sharma

The University of Texas MD Anderson Cancer Center

Jonathan A C Sterne

Jonathan A C Sterne

University of Bristol

Herbert J. Gans

Herbert J. Gans

Columbia University

Something went wrong. Please try again later.